Table 4.
I | II | IIIA | IIIB | IV | Total | ||
---|---|---|---|---|---|---|---|
Colorectal cancer | |||||||
CK20+ | 8 (36.4%) | 0 | 0 | 1 (4.5%) | 13 (59%) | 22 (100%) | |
CK20− | 18 (23.4%) | 3 (3.9%) | 12 (15.6%) | 7 (9%) | 37 (48%) | 77 (100%) | |
Breast cancer | IIA | IIB | |||||
CK20+ | 6 (18.7%) | 10 (31.2%) | 5 (15.6%) | 3 (9.4%) | 0 | 8 (25%) | 32 (100%) |
CK20− | 40 (51.2%) | 14 (18%) | 11 (14.1%) | 5 (6.4%) | 1 (1.3%) | 7 (9%) | 78 (100%) |